Core Laboratories CLB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Corporate And Other | -$513K-14.0% | -$450K-21.6% | -$370K+9.5% | -$409K-13.6% | -$360K-6.8% | |
| Operating Segment Production Enhancement | $176.02M-1.6% | $178.84M+2.0% | $175.31M+0.4% | $174.57M-0.2% | $174.99M-1.5% | |
| Operating Segment Reservoir Description | $348.72M+0.3% | $347.68M+1.6% | $342.19M-0.2% | $342.81M0.0% | $342.81M-1.0% | |
| Other Operating Income Expense Net by Business | ||||||
| Corporate And Other | $1.68M-17.2% | $2.03M— | —— | —— | —— | |
| Operating Segment Production Enhancement | $954K+236% | $284K+138% | -$748K+23.1% | -$973K-9.4% | -$889K-61.6% | |
| Operating Segment Reservoir Description | $8.61M+42.3% | $6.05M-46.8% | $11.37M+10.4% | $10.29M+2.0% | $10.09M-12.6% | |
| Operating Income by Business | ||||||
| Corporate And Other | -$148K-130% | $490K-20.7% | $618K-15.0% | $727K-23.6% | $951K+98.5% | |
| Operating Segment Production Enhancement | $11.36M-5.8% | $12.06M— | —— | —— | —— | |
| Operating Segment Reservoir Description | $42.75M-2.7% | $43.94M-8.0% | $47.76M+0.2% | $47.67M+1.6% | $46.91M-8.8% | |
| Total Assets by Business | ||||||
| Corporate And Other | $483.45M-1.1% | $488.71M-1.4% | $495.85M+0.5% | $493.22M+2.0% | $483.45M-1.0% | |
| Operating Segment Production Enhancement | $572.23M-1.4% | $580.39M-1.4% | $588.87M-2.0% | $600.65M-2.4% | $615.13M-1.9% | |
| Operating Segment Reservoir Description | $1.31B+1.2% | $1.29B+1.1% | $1.28B0.0% | $1.28B+0.7% | $1.27B+0.4% | |
| Cost of Goods Sold by Business | ||||||
| Corporate And Other | $1.16M+25.3% | $924K+9,340% | -$10K+97.7% | -$431K+29.7% | -$613K-8.7% | |
| Operating Segment Production Enhancement | $146.26M-0.8% | $147.39M-0.7% | $148.4M-0.6% | $149.34M+0.7% | $148.35M-2.3% | |
| Operating Segment Reservoir Description | $272.78M+1.3% | $269.27M+1.3% | $265.88M-0.5% | $267.27M-0.1% | $267.66M-0.6% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Corporate And Other | $257K+23.0% | $209K-2.8% | $215K+111% | $102K-68.6% | $325K+8.7% | |
| Operating Segment Production Enhancement | $1.38M-37.4% | $2.2M-3.8% | $2.29M-9.6% | $2.54M+13.8% | $2.23M+69.0% | |
| Operating Segment Reservoir Description | $14.27M+17.1% | $12.18M-5.0% | $12.81M+3.5% | $12.38M+12.5% | $11M-3.6% | |
| General And Administrative Expense by Business | ||||||
| Corporate And Other | $0— | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $15.91M+0.9% | $15.77M+2.2% | $15.44M+4.7% | $14.75M+0.9% | $14.62M+2.7% | |
| Operating Segment Reservoir Description | $30.59M+3.1% | $29.66M+4.3% | $28.44M+5.0% | $27.09M+0.3% | $27.01M+5.8% | |
| Foreign Currency Transaction Gain Loss Before Tax by Business | ||||||
| Corporate And Other | -$173K+4.4% | -$181K-64.5% | -$110K-323% | -$26K-155% | $47K-50.5% | |
| D&A by Business | ||||||
| Corporate And Other | $0— | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $4M-2.8% | $4.12M-2.4% | $4.22M-1.4% | $4.28M-0.9% | $4.32M+0.5% | |
| Operating Segment Reservoir Description | $10.7M+1.6% | $10.53M+1.0% | $10.43M-0.2% | $10.45M-0.6% | $10.51M-1.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Core Laboratories break its business down?
- Core Laboratories (CLB) reports revenue by business across 3 parts — Corporate And Other, Operating Segment Production Enhancement and Operating Segment Reservoir Description. Each is extracted from the segment footnotes and tracked over time.
- Where does Core Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Core Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
